Effect of Ayurvedic drugs on iron deficiency Anaemia during Pregnancy

A CLINICAL STUDY ON GARBHINI PANDU (WITH SPECIAL REFERENCE TO IRON DEFICIENCY ANEMIA IN PREGNANCY) & ITS MANAGEMENT WITH PUNARNAVA MANDURA & DHATRI LAUHA

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/07/006049

Enrollment

Registered

2015-07-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Garbhini Pandu-Iron Deficiency Anaemia during Pregnancy

Interventions

Intervention1: Punarnava Mandura: 2 tablets(500mg each) t.d.s., before meal with Takra (Butter Milk) for 90 days Control Intervention1: Dhatri Lauha: 2 tablets(500mg each) t.d.s., before meal with Lu

Eligibility

Inclusion criteria

Inclusion criteria: 1.The pregnant woman age group from 19 to 40 years having clinical signs & symptoms of Garbhini Pandu i.e., Panduta, Bhrama, Daurbalya, Shwasa, etc. described in Ayurvedic classics & modern literature. 2.Patients of 2nd or 3rd trimester of pregnancy 3. Patients having Hemoglobin (Hb% )equal to or less than 10gm% in 2nd and less than 11gm% in 3rd trimester and more than 6.5gm%

Exclusion criteria

Exclusion criteria: 1.Patients suffering from pregnancy related complications like PIH, hyper emesis gravidarum, pre eclampsia etc. 2.1st trimester of pregnancy. 3.Patients having with high risk pregnancy. 4.Patients having Hb% count less than 6.5gm% & more than 10gm%.

Design outcomes

Primary

Measure	Time frame
â?¢Improvement in signs and symptoms of Garbhini Pandu. â?¢Increase in Hb% Timepoint: 90 days	—

Secondary

Measure	Time frame
Improvement in other biological parametersTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Shilpa B DONGA

Institute for postgraduate teaching and research in ayurveda

deepika.yati@gmail.com7405674312

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026